Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 5/20 | 0.65 |
| ▸ | CASP1 | P29466 | 3/20 | 0.65 |
| ▸ | CASP7 | P55210 | 3/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | GAA | P10253 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.65 |
| ▸ | HBB | P68871 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | ATM | Q13315 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085116 | 0.87 | USP2 (0.62) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL26307770 | 0.80 | SLC16A3 (0.74) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL2843124 | 0.78 | SLC16A3 (0.80) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL29413851 | 0.78 | SLC16A3 (0.80) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL12511762 | 0.78 | SLC16A3 (0.83) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL10086132 | 0.78 | USP2 (0.57) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL29364862 | 0.77 | SLC16A3 (1.00) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL45609 | 0.77 | SLC16A3 (1.00) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL16900679 | 0.77 | SLC16A3 (0.70) | USP2CASP1CASP7ALOX15MEN1 | |
| SCHEMBL10082362 | 0.76 | SLC16A3 (0.80) | USP2CASP1CASP7ALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090004108-A1 | Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors | MASIMO LABORATORIES, INC. (US) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090004108-A1 | Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors | GCKR, SYMPK, SUCNR1 | USP2 3927/4885CASP1 1108/4885CASP7 1997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.